Curiyan Pharmaceutical Private Limited
About Curiyan Pharmaceutical Private Limited
Data last updated:
Curiyan Pharmaceutical Private Limited is a private limited company based in Boisar, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 18 August 2022.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2022PTC388775.
The company has an authorised share capital of ₹10 Lakh. It is led by directors Ravi Ranjan and Kumar Bhenu Gopal.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at A6 Shanidham Keshav Nagar Boisar, Maharashtra, India – 401501.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.4 Lakh, a decline of 64% compared to the previous year. For the same year it recorded a net profit of ₹3,589 (net margin 1.5%) and EBITDA of ₹4,859 (EBITDA margin 2%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Curiyan Pharmaceutical Private Limited's registered office is in Boisar, Maharashtra.
- Registered AddressA6 Shanidham Keshav Nagar Boisar, Maharashtra, India – 401501
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Curiyan Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Curiyan Pharmaceutical Private Limited, buy the company report.
Financials of Curiyan Pharmaceutical Private Limited
FY 2024 filings availableCuriyan Pharmaceutical Private Limited reported revenue of ₹2.4 Lakh (down 64% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 64% in the latest year. EBITDA fell 97% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹4,859 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹3,589 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 2% | |
| Net Profit Margin | 1.5% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Curiyan Pharmaceutical Private Limited, buy the company report.
Board of directors of Curiyan Pharmaceutical Private Limited
Curiyan Pharmaceutical has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ravi Ranjan | Director | 18 Aug 2022 | 4 Years 2 Months | Current |
| Kumar Bhenu Gopal | Director | 18 Aug 2022 | 4 Years 2 Months | Current |
Peer comparison
Curiyan Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Jito&Karan Industries Private Limited | ₹2.43 Lakh (FY 2025) | -63.0% | Durgapur, West Bengal, India | |||
| Bezwingen Pharma Private Limited | ₹2.42 Lakh (FY 2024) | Eranhipalam, Kerala, India | ||||
| Sorrell Pharmaceuticals Private Limited | ₹2.42 Lakh (FY 2022) | 88.0% | Hyderabad, Telangana, India | |||
| Neodivine Pharma Private Limited | ₹2.41 Lakh (FY 2024) | 84.0% | Noida, Uttar Pradesh, India | |||
| Sadashiv Metalics Private Limited | ₹2.4 Lakh (FY 2025) | 0.0% | Chandigarh, India | |||
| Curiyan Pharmaceutical Private Limitedthis company | ₹2.4 Lakh (FY 2024) | ₹3,589 | 1.5% | -64.0% | Boisar, Maharashtra, India | |
| Vardhman Pharmaceuticals Private Limited | ₹2.39 Lakh (FY 2025) | -8.0% | Uttar Pradesh, India | |||
| Lifeherbs Laboratories Private Limited | ₹2.39 Lakh (FY 2024) | -24.0% | Jalaun, Uttar Pradesh, India | |||
| Rakmind Lifescience Private Limited | ₹2.38 Lakh (FY 2019) | 50.0% | Thane, Maharashtra, India | |||
| Aqua Medicare Private Limited | ₹2.38 Lakh (FY 2019) | 4.0% | Kolkata, West Bengal, India | |||
| Stephen Pharmaceutical Private Limited | ₹2.36 Lakh (FY 2016) | 5.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Curiyan Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Curiyan Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Curiyan Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Curiyan Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Curiyan Pharmaceutical Private Limited has 3 board changes on record since 2022: 2 appointments and 1 cessation. The latest: Sundaram Snehi ceased to be Director on 09 Oct 2023.
Frequently asked questions
Curiyan Pharmaceutical is an active private limited company based in Boisar, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 18 August 2022 (4+ years old) and is registered under CIN U24230MH2022PTC388775.
Curiyan Pharmaceutical has 2 current directors:
- Ravi Ranjan - Director
- Kumar Bhenu Gopal - Director
The latest financial statements of Curiyan Pharmaceutical on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Curiyan Pharmaceutical is U24230MH2022PTC388775. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Curiyan Pharmaceutical was incorporated on 18 August 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Curiyan Pharmaceutical by revenue are Jito&Karan Industries Private Limited, Bezwingen Pharma Private Limited, Sorrell Pharmaceuticals Private Limited, Neodivine Pharma Private Limited, Sadashiv Metalics Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sundaram Snehi ceased to be Director on 09 Oct 2023. Kumar Bhenu Gopal was appointed as Director on 18 Aug 2022. Ravi Ranjan was appointed as Director on 18 Aug 2022.
The registered office of Curiyan Pharmaceutical is at A6 Shanidham Keshav Nagar Boisar, Maharashtra, India – 401501.
Curiyan Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Curiyan Pharmaceutical is compliant as of 12 September 2026. The company is actively filing with the Registrar of Companies.
Curiyan Pharmaceutical can be reached at its registered office: A6 Shanidham Keshav Nagar Boisar, Maharashtra, India – 401501.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
